WU Shield

WU Biology Department

 

1999 Summer Scholars Program

blank picture

Previous: Lin Lin

Scholars Index

Next: Grace Messah

blank picture



Assessing the Specificity of APC CC-1 Labeling in vivo and in vitro

By Kristina N. Mays
Mentor: Dr. John W. McDonald, M.D. Ph. D.
Department of Neurology, Washington University School of Medicine, St. Louis, MO
Kristina N. Mays


Antibodies belong to the group of serum proteins known as immunoglobins. Immunocytochemistry is a technique that utilizes the highly specific antibody-antigen relationship to evaluate cellular phenotype and mechanisms. Having a basic understanding of the scope, or specificity, of each antibody allows scientists to effectively employ them in lab. Adenomatous Polyposis Coli is a gene found in tissues throughout the body. Mutations in the APC gene result in a dominant allele based disorder called Familial Adenomatous Polyposis (FAP), or Gardner's Syndrome. FAP is characterized by cancerous tumors in the colon, thyroid, and brain as well as the development of polyps in the upper gastrointestinal tract and colon. The APC CC- I antibody is used with increasing frequency in neuroscience laboratories because it has been experimentally proven to label the cell bodies of oligodendrocytes in in vivo studies.

Oligodendrocytes are components of the glia of the central nervous system, the brain and spinal cord. The developmental cycle of oligodendrocytes can be defined by a series of distinct proteins expressed during certain phases of the cell's maturation. Using this method, the oligodendrocyte lineage is divided into four stages: the progenitor stage characterized by NG2 expression, the preoligodendrocyte stage denoted by 04 expression, the mature oligodendrocyte stage delineated by 01 expression, and the terminally mature oligodendrocyte stage identified by myelin basic protein expression. Mature oligodendrocytes, those with 01 and MBP expression, are responsible for creating the myelin sheath, a thin membrane surrounding neurons that allows for the rapid transmission of signals between the brain and peripheral organs.

Damage to the white matter, myelin and surrounding cells, has been studied in the mature nervous system. Analysis of the injury has primarily been done through single labeling immunocytochemistry, which employs one primary antibody and one secondary antibody. The primary antibody labels the cell, and the fluorescent secondary labels the primary, permitting the cell to be viewed under epifluorescent light. APC CC- I has been used to label oligodendrocytes in these studies because of its unique ability to label only the cell bodies of oligodendrocytes. Other antibodies that label oligodendrocytes tend to also label all processes and the surrounding myelin, making the individual cells indistinguishable when examining tissue from the damaged central nervous system. In previous studies, it has been assumed that all cells labeled by APC CC-I in the mature nervous system are myelinating oligodendrocytes because there are few progenitors and preoligodendrocytes in the mature nervous system; however, double labeling was never done to prove this. After injury, there are inflated numbers of cells labeled that researchers believe are mature oligodendrocytes; however, after injury, mature oligodendrocytes can dedifferentiate and progenitors produce new oligodendrocytes. Thus, this study sought to prove that APC CC- I labels only mature oligodendrocytes by double-labeling cultures of oligodendrocytes and cultures of embryonic stem cells with a lineage-specific marker and APC CC-1. The following observations were made:

in vitro
in vivo

Embryonic Stem Cell Culture
Oligodendrocyte Cell Culture
Spinal Cord Sections

NG2

light labeling

light labeling

 

04

 

 

 

01

 

 

 

MBP

dark labeling

dark labeling

strong labeling

GFAP

light labeling

light labeling

 

Note: Any labeling with GFAP is an indication that the APC gene is expressed.

Based on this study, the APC CC-1 antibody labels mature oligodendrocytes and lightly labels progenitors and astrocytes; therefore, in analyzing white matter injury, double labeling with NG2, GFAP and MBP is necessary to ensure that the damage is assessed accurately.



blank picture

Previous: Lin Lin

Scholars Index

Next: Grace Messah

blank picture

This page was last updated on Fri, Jun 16, 2000 at 2:16:31 PM by Tom Elgin with Userland Frontier.